MyAverix Finance
V · Healthcare
Sharp Therapeutics Corp. (SHRX)
Biotechnology
Sharp Therapeutics Corp. (SHRX) is listed on V in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SHRX
Sharp Therapeutics Corp. (SHRX) — FAQ
What is SHRX's P/E ratio?
The price-to-earnings (P/E) ratio for Sharp Therapeutics Corp. (SHRX) is 18.00 (data as of 2026-03-23).
Does Sharp Therapeutics Corp. pay a dividend?
Dividend yield is not available in the current snapshot for Sharp Therapeutics Corp. (SHRX). Check the MyAverix Finance app for the latest dividend data.
What sector is Sharp Therapeutics Corp. in?
Sharp Therapeutics Corp. (SHRX) is classified in the Healthcare sector (Biotechnology industry).
What exchange is SHRX listed on?
SHRX is listed on V.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.